Clinical Trial

Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy

Study acronym: AUTOGRAFTIM
Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The liver may not be an optimal site for islet transplantation due to obstacles by an instant blood-mediated inflammatory response, and low revascularization of transplanted islets. Therefore, intramuscular islet transplantation offers an attractive alternative, based on its simplicity, enabling easier access for noninvasive graft imaging and cell explantation.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2016-08-16; most recent amendment 2026-04-17.
Status change: Recruiting → Active, Not Recruiting 2022-06-30
Trial Details
NCT Number NCT02872571
Lead Sponsor University Hospital, Lille
Conditions Disorder of Endocrine Pancreas
Enrollment 35 participants
Start Date 2013-03
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-22